EVO ICL SURGERY MONTREAL

EVO ICL lens surgery is intended to safely and effectively correct near-sightedness (-3.0 to -18.0 dioptres (D)), the reduction of near-sightedness in patients with up to -20 dioptres (D) of near-sightedness, treatment of astigmatism from +0.5D to +6D and correction of farsightedness from 0.5 to 10.0D. It is indicated for patients who are at least 21 years of age.
In order to be sure that your surgeon will use an EVO ICL lens with the most adequate power for your eye, your near-sightedness should be stable for at least a year before undergoing eye surgery.
The EVO ICL represents an alternative to other refractive surgeries including laser-assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), other laser vision correction procedures, incisional surgeries, or other means to correct myopia such as contact lenses and eyeglasses.

Pregnant patients who are nursing, as well as patients with a narrow front chamber of their eye, because in this case, the space for the EVO ICL lens would be too small. The patient education booklet provides an additional list of conditions that should be taken into consideration when making a decision about the EVO ICL procedure.

The key benefit of EVO ICL surgery is the permanent correction or reduction of your nearsightedness and treatment of astigmatism allowing you to see clearly at long distances without eyeglasses or contact lenses or reduce your dependence upon them. In addition to the improvement of your uncorrected vision (vision without eyeglasses or contact lenses), your best-corrected vision (best vision with contact lenses/eyeglasses) may be improved. It’s also important to know that EVO ICL is very well tolerated by people with dry eyes and is a popular choice among patients seeking natural visual freedom with their evo eye.

Follow all of your eye care professional’s instructions before and after the implantation of the EVO ICL lens. Take any prescribed medication and schedule all recommended follow-up visits with your eye care professional, usually on an annual basis after the healing of the EVO ICL surgery. Contact your eye care professional immediately should you experience a problem.

The material is called Collamer®, a collagen co-polymer that contains a small amount of purified collagen which is proprietary to STAAR Surgical; the remainder is made of a similar material to that found in soft contact lenses. It is very biocompatible (does not cause a reaction inside the eye) and stable. It also contains an ultraviolet light filter.

Prior to being placed on the market, EVO ICL was subject to extensive research and development. Today, more than 3 millions lenses have been implanted worldwide. In a survey, over 99.4 percent of patients were satisfied with their implants. EVO ICL has a track record of excellent clinical outcomes. Additionally, the EVO ICL lens has been available internationally for over 10 years.

EVO ICL is intended to remain in place without maintenance. EVO ICL can be removed by your eye care professional if needed in the future.

No. EVO ICL is positioned behind the iris (the colored part of the eye), where it is invisible to both you and others. Only your eye care practitioner will be able to tell that vision correction has taken place.

EVO ICL is not typically noticeable after it is implanted. It does not attach to any structures within the eye and does not move around once in place.

The EVO ICL surgery is performed on an outpatient basis which means that the patient has surgery and leaves the same day. The procedure itself usually takes 20-30 minutes or less. The patient will need someone to drive them home on surgery day. A light, topical, or local anesthetic is administered, often accompanied by a mild sedative to ensure comfort. There is very little discomfort during or after surgery. Some eye drops or medication may be prescribed and a visit with your eye care professional is usually scheduled the day after surgery. This quick and virtually painless process is what makes EVO ICL surgery in Montreal a sought-after option for vision correction.

Implantable contact lenses, such as the EVO ICL lens, are designed to provide long-lasting vision correction. Made from biocompatible Collamer®, these lenses are stable and well tolerated by the eye, allowing them to remain in place indefinitely without the need for replacement. However, if your eye health or prescription changes over time, the implantable lens can be safely removed or replaced by your eye care professional during a surgical procedure.

The cost of EVO ICL surgery in Montreal varies depending on individual patient needs and the complexity of the procedure. Factors such as pre-operative evaluations, lens customization, and post-operative care are included in the overall price. While the initial investment may be higher than traditional contact lenses or glasses, EVO ICL offers a permanent vision correction alternative that can reduce or eliminate your dependence on glasses or contact lenses. For an accurate estimate and detailed financing options, it is recommended to schedule a complete eye examination and consultation with a qualified eye care professional.

EVO ICL and LASIK surgery are both effective vision correction procedures, but they differ significantly. EVO ICL surgery is a reversible surgical procedure that implants a soft, implantable lens behind the iris without removing corneal tissue, making it an excellent option for patients with thin corneas or dry eye syndrome who may not qualify for LASIK. LASIK surgery reshapes the cornea permanently using laser technology, which may not be suitable for everyone. Many patients experience immediate and clear vision improvement with EVO ICL, and it offers less risk of ocular dryness compared to laser surgery. Choosing the best procedure depends on your eye health, stable prescription, and personal preferences, so a complete eye examination and consultation with an eye care professional are essential to determine the most adequate option for your vision correction needs.